#VisualAbstract: Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma
Bookmark1. Disease-free survival at 24 months was 84% in the nivolumab group compared to 73% in...
Read More
studygraphics
#VisualAbstract: Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read More
#VisualAbstract: Ferric Carboxymaltose in Heart Failure with Iron Deficiency
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read More
#VisualAbstract: Retatrutide effectively reduces body weight in patients with obesity
Bookmark©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without...
Read More
#VisualAbstract: Baricitinib is safe and effective for treatment of refractory juvenile idiopathic arthritis
Bookmark ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without...
Read More
#VisualAbstract: Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes
BookmarkClick to read the study in The New England Journal of Medicine ©2023 2 Minute Medicine,...
Read More
#VisualAbstract:Oral semaglutide effectively reduces bodyweight in non-diabetic adults with obesity
Bookmark1. The semaglutide 50 mg group saw a 15.1% reduction in body weight at 68 weeks compared...
Read More
#VisualAbstract: Extracorporeal Life Support in Infarct-Related Cardiogenic Shock
BookmarkClick to read the study in The New England Journal of Medicine ©2023 2 Minute Medicine,...
Read More
#VisualAbstract: Prehospital Tranexamic Acid for Severe Trauma
BookmarkClick to read the study in The New England Journal of Medicine ©2023 2 Minute Medicine,...
Read More
#VisualAbstract: Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2)
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read More
#VisualAbstract: Antibody NI006 for treatment of transthyretin amyloid cardiomyopathy caused no serious adverse events
Bookmark©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without...
Read More
#VisualAbstract: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read More
#VisualAbstract: Low-dose glucocorticoids for rheumatoid arthritis do not increase blood pressure
Bookmark1. In this pooled analysis of randomized controlled trials, low-dose glucocorticoids...
Read More
#VisualAbstract: Pitavastatin reduces cardiovascular event risk among patients with HIV
Bookmark1. In this randomized controlled trial, among patients living with human immunodeficiency...
Read More
#VisualAbstract: Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction
BookmarkClick to read the study in The New England Journal of Medicine ©2023 2 Minute Medicine,...
Read More
#VisualAbstract: Trends in the prevalence of Hepatitis C infection during pregnancy and maternal-infant outcomes in the US, 1998 to 2018
Bookmark1. The prevalence of Hepatitis C infection during pregnancy increased between 1998 and...
Read More
#VisualAbstract: Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation
Bookmark Click to read the study in The New England Journal of Medicine ©2023 2 Minute Medicine,...
Read More
#VisualAbstract: Timing of primary surgery for infants with cleft palate
BookmarkClick here to view this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read More
#VisualAbstract: Number of negative lymph nodes removed during gastrectomy for gastric cancer may predict survival
Bookmark1. This retrospective study found that patients undergoing gastrectomy for gastric cancer...
Read More
#VisualAbstract: Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
BookmarkClick to view this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read More